Gu Yuhang, Zhou Chen, Piao Zhe, Yuan Honghua, Jiang Huimin, Wei Huimin, Zhou Yifan, Nan Guangxian, Ji Xunming
Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Beijing Institute of Brain Disorders, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Capital Medical University, Beijing, China.
Front Neurosci. 2022 Aug 18;16:988283. doi: 10.3389/fnins.2022.988283. eCollection 2022.
Ischemic stroke is associated with increasing morbidity and has become the main cause of death and disability worldwide. Cerebral edema is a serious complication arising from ischemic stroke. It causes an increase in intracranial pressure, rapid deterioration of neurological symptoms, and formation of cerebral hernia, and is an important risk factor for adverse outcomes after stroke. To date, the detailed mechanism of cerebral edema after stroke remains unclear. This limits advances in prevention and treatment strategies as well as drug development. This review discusses the classification and pathological characteristics of cerebral edema, the possible relationship of the development of cerebral edema after ischemic stroke with aquaporin 4, the SUR1-TRPM4 channel, matrix metalloproteinase 9, microRNA, cerebral venous reflux, inflammatory reactions, and cerebral ischemia/reperfusion injury. It also summarizes research on new therapeutic drugs for post-stroke cerebral edema. Thus, this review provides a reference for further studies and for clinical treatment of cerebral edema after ischemic stroke.
缺血性中风与发病率上升相关,已成为全球死亡和残疾的主要原因。脑水肿是缺血性中风引发的一种严重并发症。它会导致颅内压升高、神经症状迅速恶化以及脑疝形成,并且是中风后不良后果的一个重要危险因素。迄今为止,中风后脑水肿的详细机制仍不清楚。这限制了预防和治疗策略以及药物研发的进展。本综述讨论了脑水肿的分类和病理特征、缺血性中风后脑水肿的发生与水通道蛋白4、SUR1-TRPM4通道、基质金属蛋白酶9、微小RNA、脑静脉回流、炎症反应以及脑缺血/再灌注损伤之间可能存在的关系。它还总结了中风后脑水肿新型治疗药物的研究情况。因此,本综述为进一步研究以及缺血性中风后脑水肿的临床治疗提供了参考。